Related Experiment Video
Updated: Jul 13, 2026

Mechanical Control of Relaxation Using Intact Cardiac Trabeculae
Published on: February 17, 2023
Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy
Claudia Stöllberger1, Josef Finsterer
1Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Vienna, Austria. claudia.stoellberger@chello.at
Insights
Restrictive cardiomyopathy (RCMP) involves impaired heart filling. Investigating underlying systemic diseases is crucial for potential causal therapies beyond managing heart congestion.
Area of Science:
- Cardiology
- Internal Medicine
- Pathology
Background:
- Restrictive cardiomyopathy (RCMP) is defined by impaired ventricular filling and reduced diastolic volume, with preserved systolic function.
- RCMP can be idiopathic or a manifestation of various systemic diseases, including scleroderma, amyloidosis, and sarcoidosis.
Purpose of the Study:
- To emphasize the importance of investigating extracardiac diseases in patients diagnosed with restrictive cardiomyopathy.
- To highlight the potential for causal therapy when RCMP is linked to a treatable underlying systemic disorder.
Main Methods:
- Comprehensive patient evaluation including clinical history, physical examination, and laboratory tests.
- Systematic assessment of ophthalmologic, otologic, dermatologic, gastroenterologic, nephrologic, hematologic, and neurologic systems.
- Consideration of endomyocardial biopsy if extracardiac investigations are inconclusive.
Main Results:
- Idiopathic RCMP management focuses on cardiac congestion relief.
- Systemic diseases associated with RCMP may offer opportunities for causal treatment.
- Early detection of underlying causes is vital before the condition becomes untreatable.
Conclusions:
- Prompt investigation for extracardiac causes is essential upon RCMP diagnosis.
- Identifying and treating underlying systemic diseases can significantly alter RCMP prognosis.
- A multidisciplinary diagnostic approach, potentially including endomyocardial biopsy, is key for comprehensive patient care.
Abstract:
Restrictive cardiomyopathy (RCMP) is characterized by restrictive filling and reduced diastolic volume of either or both ventricles with normal or near-normal systolic function and wall thickness. It may occur idiopathically or as a cardiac manifestation of systemic diseases such as scleroderma, amyloidosis, Churg-Strauss syndrome, cystinosis, sarcoidosis, lymphoma, Gaucher's disease, hemochromatosis, Fabry's disease, pseudoxanthoma elasticum, hypereosinophilic syndrome, carcinoid, Noonan's syndrome, reactive arthritis, or Werner's syndrome and various neuromuscular disorders. Whereas in idiopathic RCMP the therapeutic options are only treatment of cardiac congestion, in cases with an underlying disorder, a causal therapy may be available. Patients with RCMP should be investigated as soon as the cardiac diagnosis is established for extracardiac diseases to detect a possibly treatable cause of RCMP before the disease becomes intractable. These investigations include a diligent clinical history and examination, blood tests, and ophthalmologic, otologic, dermatologic, gastroenterologic, nephrologic, hematologic, and neurologic examinations. If extracardiac examinations do not reveal a plausible cause for RCMP, endomyocardial biopsy is indicated.
More Related Videos
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management

